Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilio Santander

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 16, 2004
Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosisConrado M Fernández-Rodriguez, Julian Romero, Timothy J Petros, et al.
Therapeutic Advances in Gastroenterology|August 21, 2019
Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptomsBlanca Serrano-Falcón, Sílvia Delgado-Aros, Fermín Mearin, et al.
Medicine|November 16, 2018
Phase IV noninferiority controlled randomized trial to evaluate the impact on diagnostic thinking and patient management and the test-retest reproducibility of the Gaxilose test for hypolactasia diagnosisCarmen Monsalve-Hernando, Laura Crespo, Blanca Ferreiro, et al.
Nutrients|November 6, 2019
Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel DiseaseSamuel Fernández-Tomé, Alicia C Marin, Lorena Ortega Moreno, et al.
Biomedicines|August 26, 2022
Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel DiseaseIrene Soleto, Samuel Fernández-Tomé, Irene Mora-Gutiérrez, et al.
Frontiers in Immunology|April 22, 2024
Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatmentLola Ugalde-Triviño, Francisca Molina-Jiménez, Juan H-Vázquez, et al.
Molecular Nutrition & Food Research|April 23, 2021
Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal TractSamuel Fernández-Tomé, Pedro Indiano-Romacho, Irene Mora-Gutiérrez, et al.
Clinical and Translational Gastroenterology|October 23, 2025
Artificial Intelligence Driven Diagnosis of Motility Patterns in High-Resolution Esophageal Manometry: A Multicentric Multidevice StudyMiguel Mascarenhas, Joana Mota, João Rala Cordeiro, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2020
Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registryEmilio J Laserna-Mendieta, Sergio Casabona, Danila Guagnozzi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 29, 2020
Efficacy of Therapy for Eosinophilic Esophagitis in Real-World PracticeEmilio J Laserna-Mendieta, Sergio Casabona, Edoardo Savarino, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Liver International : Official Journal of the International Association for the Study of the Liver|October 16, 2004
Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosisConrado M Fernández-Rodriguez, Julian Romero, Timothy J Petros, et al.
Therapeutic Advances in Gastroenterology|August 21, 2019
Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptomsBlanca Serrano-Falcón, Sílvia Delgado-Aros, Fermín Mearin, et al.
Medicine|November 16, 2018
Phase IV noninferiority controlled randomized trial to evaluate the impact on diagnostic thinking and patient management and the test-retest reproducibility of the Gaxilose test for hypolactasia diagnosisCarmen Monsalve-Hernando, Laura Crespo, Blanca Ferreiro, et al.
Nutrients|November 6, 2019
Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel DiseaseSamuel Fernández-Tomé, Alicia C Marin, Lorena Ortega Moreno, et al.
Biomedicines|August 26, 2022
Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel DiseaseIrene Soleto, Samuel Fernández-Tomé, Irene Mora-Gutiérrez, et al.
Frontiers in Immunology|April 22, 2024
Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatmentLola Ugalde-Triviño, Francisca Molina-Jiménez, Juan H-Vázquez, et al.
Molecular Nutrition & Food Research|April 23, 2021
Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal TractSamuel Fernández-Tomé, Pedro Indiano-Romacho, Irene Mora-Gutiérrez, et al.
Clinical and Translational Gastroenterology|October 23, 2025
Artificial Intelligence Driven Diagnosis of Motility Patterns in High-Resolution Esophageal Manometry: A Multicentric Multidevice StudyMiguel Mascarenhas, Joana Mota, João Rala Cordeiro, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2020
Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registryEmilio J Laserna-Mendieta, Sergio Casabona, Danila Guagnozzi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 29, 2020
Efficacy of Therapy for Eosinophilic Esophagitis in Real-World PracticeEmilio J Laserna-Mendieta, Sergio Casabona, Edoardo Savarino, et al.
Pageof 9